Skip to main content
See every side of every news story
Published loading...Updated

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner - Emergent BioSolutions (NYSE:EBS)

Summary by Benzinga
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The orders span several product offerings within Emergent's medical countermeasures (MCM) business, including countermeasures for smallpox, anthrax and botulism threats, and reflects the increasing p…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, September 19, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal